Cibus, Inc. (CBUS)

USD 2.25

(5.14%)

Revenue Summary of Cibus, Inc.

  • Cibus, Inc.'s latest annual revenue in 2023 was 1.81 Million USD , up 1057.32% from previous year.
  • Cibus, Inc.'s latest quarterly revenue in 2024 Q2 was 838 Thousand USD , up 53.76% from previous quarter.
  • Cibus, Inc. reported a annual revenue of 157 Thousand USD in annual revenue 2022, down -99.4% from previous year.
  • Cibus, Inc. reported a annual revenue of 25.98 Million USD in annual revenue 2021, up 8.96% from previous year.
  • Cibus, Inc. reported a quarterly revenue of 545 Thousand USD for 2024 Q1, down -50.59% from previous quarter.
  • Cibus, Inc. reported a quarterly revenue of 475 Thousand USD for 2023 Q3, up 141.12% from previous quarter.

Annual Revenue Chart of Cibus, Inc. (2023 - 2015)

Historical Annual Revenue of Cibus, Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 1.81 Million USD 1057.32%
2022 157 Thousand USD -99.4%
2021 25.98 Million USD 8.96%
2020 23.85 Million USD 226.91%
2019 7.29 Million USD 2991.53%
2018 236 Thousand USD -53.54%
2017 508 Thousand USD 27.32%
2016 399 Thousand USD -68.63%
2015 1.27 Million USD 0.0%

Peer Revenue Comparison of Cibus, Inc.

Name Revenue Revenue Difference
NeuroSense Therapeutics Ltd. - USD -Infinity%
Psyence Biomedical Ltd. - USD -Infinity%
XOMA Corporation 4.75 Million USD 61.812%
Mesoblast Limited 5.9 Million USD 69.214%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 98.891%
Aptorum Group Limited 431.37 Thousand USD -321.208%
Qualigen Therapeutics, Inc. 5.2 Million USD 65.09%
HilleVax, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 96.271%
Dyadic International, Inc. 2.89 Million USD 37.319%
Intensity Therapeutics, Inc. - USD -Infinity%
IDEAYA Biosciences, Inc. 23.38 Million USD 92.23%
Eton Pharmaceuticals, Inc. 31.64 Million USD 94.258%
VYNE Therapeutics Inc. 424 Thousand USD -328.538%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 96.052%
Adaptive Biotechnologies Corporation 170.27 Million USD 98.933%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 14.695%
Opthea Limited 261.85 Thousand USD -593.885%
Milestone Pharmaceuticals Inc. 1 Million USD -81.7%
Abeona Therapeutics Inc. 3.5 Million USD 48.086%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 76.609%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 98.616%
NextCure, Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -597.505%
Ovid Therapeutics Inc. 391.69 Thousand USD -363.881%
CASI Pharmaceuticals, Inc. 33.87 Million USD 94.637%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 98.848%
Syros Pharmaceuticals, Inc. 9.93 Million USD 81.713%
Senti Biosciences, Inc. 2.56 Million USD 29.051%
Apollomics, Inc. 821 Thousand USD -121.315%
PureTech Health plc 3.33 Million USD 45.435%
Oncternal Therapeutics, Inc. 785 Thousand USD -131.465%
Barinthus Biotherapeutics plc 802 Thousand USD -126.559%
Kymera Therapeutics, Inc. 78.59 Million USD 97.688%
ChromaDex Corporation 83.57 Million USD 97.826%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.066%
Sangamo Therapeutics, Inc. 176.23 Million USD 98.969%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD -36.514%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Fate Therapeutics, Inc. 63.53 Million USD 97.14%
BioXcel Therapeutics, Inc. 1.38 Million USD -31.667%
Fortress Biotech, Inc. 84.51 Million USD 97.85%
Checkpoint Therapeutics, Inc. 103 Thousand USD -1664.078%
Atossa Therapeutics, Inc. - USD -Infinity%
Lyell Immunopharma, Inc. 130 Thousand USD -1297.692%
Celcuity Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.367%
GH Research PLC - USD -Infinity%
HOOKIPA Pharma Inc. 20.12 Million USD 90.973%
Cassava Sciences, Inc. - USD -Infinity%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -332.619%
ImmuCell Corporation 17.47 Million USD 89.6%
Amarin Corporation plc 306.91 Million USD 99.408%
TG Therapeutics, Inc. 233.66 Million USD 99.222%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Seer, Inc. 15.18 Million USD 88.032%
Novavax, Inc. 983.7 Million USD 99.815%
Phathom Pharmaceuticals, Inc. 682 Thousand USD -166.422%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.953%
AnaptysBio, Inc. 17.15 Million USD 89.41%
Aptevo Therapeutics Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 95.222%
CorMedix Inc. - USD -Infinity%
Cartesian Therapeutics, Inc. 26 Million USD 93.013%
Marker Therapeutics, Inc. 3.31 Million USD 45.125%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.986%
Aptose Biosciences Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD -116.475%
Century Therapeutics, Inc. 2.23 Million USD 18.702%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.245%
TransCode Therapeutics, Inc. - USD -Infinity%
Kura Oncology, Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 98.54%
Ainos, Inc. 122.11 Thousand USD -1387.978%
TScan Therapeutics, Inc. 21.04 Million USD 91.368%
Ocean Biomedical, Inc. - USD -Infinity%
Prothena Corporation plc 91.37 Million USD 98.011%
CytomX Therapeutics, Inc. 101.21 Million USD 98.205%
Autolus Therapeutics plc 1.69 Million USD -7.008%
Mineralys Therapeutics, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 60.28 Million USD 96.986%
Eterna Therapeutics Inc. 68 Thousand USD -2572.059%
Celularity Inc. 22.77 Million USD 92.021%
Rallybio Corporation - USD -Infinity%
GRI Bio, Inc. 21.76 Million USD 91.653%
Xenetic Biosciences, Inc. 2.53 Million USD 28.464%
Omeros Corporation - USD -Infinity%
INmune Bio, Inc. 155 Thousand USD -1072.258%
Heron Therapeutics, Inc. 127.04 Million USD 98.57%
SAB Biotherapeutics, Inc. 2.23 Million USD 18.847%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 78.806%
Coherus BioSciences, Inc. 257.24 Million USD 99.294%
Immunocore Holdings plc 249.42 Million USD 99.272%
Cocrystal Pharma, Inc. - USD -Infinity%
Verastem, Inc. - USD -Infinity%
Pliant Therapeutics, Inc. 1.58 Million USD -15.0%
Histogen Inc. 3.76 Million USD 51.791%
Surrozen, Inc. - USD -Infinity%
Blueprint Medicines Corporation 249.38 Million USD 99.271%
Organovo Holdings, Inc. 109 Thousand USD -1566.972%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
IO Biotech, Inc. - USD -Infinity%
MEI Pharma, Inc. 65.29 Million USD 97.217%
GT Biopharma, Inc. - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 73.486%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -36240.0%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 94.137%
BioRestorative Therapies, Inc. 145.8 Thousand USD -1146.228%
Turnstone Biologics Corp. 19.3 Million USD 90.588%
Pulmatrix, Inc. 7.29 Million USD 75.103%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 98.965%
Vigil Neuroscience, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 94.991%
Cytokinetics, Incorporated 7.53 Million USD 75.87%
Exelixis, Inc. 1.83 Billion USD 99.901%
Nurix Therapeutics, Inc. 76.98 Million USD 97.64%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.542%
Evogene Ltd. 5.64 Million USD 67.784%
Replimune Group, Inc. - USD -Infinity%
PDS Biotechnology Corporation - USD -Infinity%
Hoth Therapeutics, Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 62.146%
Avid Bioservices, Inc. 139.91 Million USD 98.701%
Insmed Incorporated 305.2 Million USD 99.405%
VistaGen Therapeutics, Inc. 1.06 Million USD -70.771%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 9.15%
MediWound Ltd. 18.68 Million USD 90.276%
MiMedx Group, Inc. 321.47 Million USD 99.435%
OmniAb, Inc. 34.16 Million USD 94.682%
Alector, Inc. 97.06 Million USD 98.128%
Seres Therapeutics, Inc. 126.32 Million USD 98.562%
PTC Therapeutics, Inc. 937.82 Million USD 99.806%
Mereo BioPharma Group plc 10 Million USD 81.83%
Zai Lab Limited 266.71 Million USD 99.319%
Revance Therapeutics, Inc. 234.04 Million USD 99.224%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Dyne Therapeutics, Inc. - USD -Infinity%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 89.586%
Veracyte, Inc. 361.05 Million USD 99.497%
InMed Pharmaceuticals Inc. 4.59 Million USD 60.48%
FibroGen, Inc. 147.75 Million USD 98.77%
SeaStar Medical Holding Corporation - USD -Infinity%
Allakos Inc. - USD -Infinity%
scPharmaceuticals Inc. 13.59 Million USD 86.633%
Fulcrum Therapeutics, Inc. 2.8 Million USD 35.223%
Corcept Therapeutics Incorporated 482.37 Million USD 99.623%
Adial Pharmaceuticals, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -1129.322%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.523%
Precigen, Inc. 6.22 Million USD 70.811%
Fortrea Holdings Inc. 3.1 Billion USD 99.942%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Incyte Corporation 3.69 Billion USD 99.951%
Alzamend Neuro, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 91.334%
XBiotech Inc. - USD -Infinity%
Aligos Therapeutics, Inc. 15.52 Million USD 88.299%
Jasper Therapeutics, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.511%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD -16.624%
Foghorn Therapeutics Inc. 34.15 Million USD 94.68%
Agenus Inc. 156.31 Million USD 98.838%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 97.858%
Theravance Biopharma, Inc. 57.42 Million USD 96.836%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.582%
Metagenomi, Inc. Common Stock 44.75 Million USD 95.94%
Lexaria Bioscience Corp. 226.2 Thousand USD -703.243%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.452%
UroGen Pharma Ltd. 82.71 Million USD 97.803%
Gain Therapeutics, Inc. 55.18 Thousand USD -3192.86%
Sutro Biopharma, Inc. 153.73 Million USD 98.818%
Creative Medical Technology Holdings, Inc. 9000.00 USD -20088.889%
Lisata Therapeutics, Inc. - USD -Infinity%
Chemomab Therapeutics Ltd. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 79.305%
Chimerix, Inc. 324 Thousand USD -460.802%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Outlook Therapeutics, Inc. - USD -Infinity%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -616.559%
Pluri Inc. 326 Thousand USD -457.362%
Cue Biopharma, Inc. 5.49 Million USD 66.903%
MeiraGTx Holdings plc 14.01 Million USD 87.037%
Aprea Therapeutics, Inc. 583.23 Thousand USD -211.54%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 97.157%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Scholar Rock Holding Corporation - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Elicio Therapeutics, Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 63.628%
Nutriband Inc. 2.08 Million USD 12.867%
Protara Therapeutics, Inc. - USD -Infinity%
Vor Biopharma Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 98.544%
ProKidney Corp. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 81.817%
Daré Bioscience, Inc. 2.8 Million USD 35.289%
BridgeBio Pharma, Inc. 9.3 Million USD 80.469%
Titan Pharmaceuticals, Inc. 184 Thousand USD -887.5%
Bicycle Therapeutics plc 26.97 Million USD 93.264%
Tango Therapeutics, Inc. 36.52 Million USD 95.026%
Galectin Therapeutics Inc. - USD -Infinity%
Revolution Medicines, Inc. Warrant 11.58 Million USD 84.309%
Atai Life Sciences N.V. 314 Thousand USD -478.662%
Renovaro Biosciences Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
MediciNova, Inc. 1 Million USD -81.7%
Praxis Precision Medicines, Inc. 2.44 Million USD 25.746%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -10547.524%
GeoVax Labs, Inc. - USD -Infinity%
Protagonist Therapeutics, Inc. 60 Million USD 96.972%
Axsome Therapeutics, Inc. 270.6 Million USD 99.329%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Erasca, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 91.232%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.328%
bluebird bio, Inc. 29.49 Million USD 93.84%
Ventyx Biosciences, Inc. - USD -Infinity%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 95.756%
Imunon, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.925%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -1812.632%
Larimar Therapeutics, Inc. - USD -Infinity%
DBV Technologies S.A. 15.72 Million USD 88.447%
Fortress Biotech, Inc. 84.51 Million USD 97.85%
Avidity Biosciences, Inc. 9.56 Million USD 80.994%
Kezar Life Sciences, Inc. 7 Million USD 74.043%
aTyr Pharma, Inc. 353 Thousand USD -414.731%
Viridian Therapeutics, Inc. 314 Thousand USD -478.662%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -14967.584%
Galecto, Inc. - USD -Infinity%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.781%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD -50.914%
Entera Bio Ltd. - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 98.749%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 98.921%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 34.167%
Spruce Biosciences, Inc. 10.08 Million USD 81.99%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.057%
Lexaria Bioscience Corp. 226.2 Thousand USD -703.243%
Portage Biotech Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -10547.524%
Olema Pharmaceuticals, Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD -20.892%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 83.42%
Onconetix, Inc. 58.46 Thousand USD -3007.842%
MacroGenics, Inc. 58.74 Million USD 96.907%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Ocuphire Pharma, Inc. 19.04 Million USD 90.461%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD -181.629%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 81.872%
Carmell Therapeutics Corporation - USD -Infinity%
Adagene Inc. 18.11 Million USD 89.968%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.926%
Inhibrx Biosciences, Inc. 1.8 Million USD -0.944%
GlycoMimetics, Inc. 10 Thousand USD -18070.0%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.371%
Protagenic Therapeutics, Inc. - USD -Infinity%
SciSparc Ltd. 2.87 Million USD 36.888%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 77.305%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 96.952%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.901%
ADMA Biologics, Inc. 258.21 Million USD 99.296%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 98.445%
Clene Inc. 654 Thousand USD -177.829%
Celldex Therapeutics, Inc. 6.88 Million USD 73.602%
Cogent Biosciences, Inc. - USD -Infinity%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 95.924%
Adicet Bio, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 96.366%
Absci Corporation 5.71 Million USD 68.223%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD -67.93%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 250 Million USD 99.273%
Surrozen, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 69.224%
Astria Therapeutics, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 94.73%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Janux Therapeutics, Inc. 8.08 Million USD 77.521%
Invivyd, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 92.887%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 98.122%
Jaguar Health, Inc. 9.76 Million USD 81.385%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 98.19%
Clearside Biomedical, Inc. 8.22 Million USD 77.912%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.75%
Capricor Therapeutics, Inc. 25.17 Million USD 92.783%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 71.104%
Innoviva, Inc. 310.46 Million USD 99.415%
Bolt Biotherapeutics, Inc. 7.87 Million USD 76.93%
Entrada Therapeutics, Inc. 129.01 Million USD 98.592%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 97.892%
Evaxion Biotech A/S 73.11 Thousand USD -2385.228%
Ocular Therapeutix, Inc. 58.44 Million USD 96.891%
Verve Therapeutics, Inc. 11.75 Million USD 84.547%
Tyra Biosciences, Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
AlloVir, Inc. - USD -Infinity%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.544%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -1103.311%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 54.722%
ImmunityBio, Inc. 622 Thousand USD -192.122%
Korro Bio, Inc. - USD -Infinity%
C4 Therapeutics, Inc. 20.75 Million USD 91.246%
Kineta, Inc. 5.44 Million USD 66.612%
Lantern Pharma Inc. - USD -Infinity%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 97.41%
Celularity Inc. 22.77 Million USD 92.021%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Virax Biolabs Group Limited 156.41 Thousand USD -1061.624%
Kodiak Sciences Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 74.634%
Moderna, Inc. 6.84 Billion USD 99.973%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.769%
Adverum Biotechnologies, Inc. 3.6 Million USD 49.528%
Avalo Therapeutics, Inc. 1.92 Million USD 5.561%
Immix Biopharma, Inc. - USD -Infinity%
Eyenovia, Inc. 3787.00 USD -47879.931%
Puma Biotechnology, Inc. 235.63 Million USD 99.229%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 98.396%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Xilio Therapeutics, Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.891%
Arcellx, Inc. 110.31 Million USD 98.353%
Moolec Science SA 905.04 Thousand USD -100.763%
Cardiff Oncology, Inc. 488 Thousand USD -272.336%
LAVA Therapeutics N.V. 6.76 Million USD 73.157%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 97.706%
Regulus Therapeutics Inc. - USD -Infinity%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -666.667%
Verrica Pharmaceuticals Inc. 5.12 Million USD 64.539%
Avenue Therapeutics, Inc. - USD -Infinity%
Royalty Pharma plc 2.35 Billion USD 99.923%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD -147.591%
Notable Labs, Ltd. 310 Thousand USD -486.129%
Mersana Therapeutics, Inc. 36.85 Million USD 95.07%
Structure Therapeutics Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
89bio, Inc. - USD -Infinity%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 2.417%
Acasti Pharma Inc. - USD -Infinity%
Genelux Corporation 170 Thousand USD -968.824%
Trevi Therapeutics, Inc. - USD -Infinity%
Liquidia Corporation 17.48 Million USD 89.61%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.08%
Quantum-Si incorporated 1.08 Million USD -67.93%
Arbutus Biopharma Corporation 18.14 Million USD 89.984%
XOMA Corporation 4.75 Million USD 61.812%
ARS Pharmaceuticals, Inc. 30 Thousand USD -5956.667%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD -16.924%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 97.653%
Soleno Therapeutics, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
United Therapeutics Corporation 2.32 Billion USD 99.922%
Solid Biosciences Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -2420.041%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.259%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
uniQure N.V. 15.84 Million USD 88.531%
Windtree Therapeutics, Inc. - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 97.192%
Altimmune, Inc. 426 Thousand USD -326.526%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -393.915%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Benitec Biopharma Inc. 216 Thousand USD -741.204%
Zura Bio Limited - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.545%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 94.569%
Elevai Labs, Inc. Common Stock 1.71 Million USD -6.096%
argenx SE 1.22 Billion USD 99.852%
Zevra Therapeutics, Inc. 27.46 Million USD 93.383%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 886 Thousand USD -105.079%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 63.016%
Forte Biosciences, Inc. - USD -Infinity%
Dianthus Therapeutics, Inc. 2.82 Million USD 35.704%
Instil Bio, Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Immunome, Inc. 14.01 Million USD 87.038%
Verona Pharma plc - USD -Infinity%
Enveric Biosciences, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD -9.656%
LENZ Therapeutics, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 17.522%
Achilles Therapeutics plc - USD -Infinity%
Fractyl Health, Inc. Common Stock 120 Thousand USD -1414.167%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Beam Therapeutics Inc. 377.7 Million USD 99.519%
Moolec Science SA 905.04 Thousand USD -100.763%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
AEON Biopharma, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 92.539%
Enliven Therapeutics, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD -52.817%
Taysha Gene Therapies, Inc. 15.45 Million USD 88.24%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD -118.387%
Athira Pharma, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 36.062%
XOMA Corporation 4.75 Million USD 61.812%
NeurAxis, Inc. 2.46 Million USD 26.14%
Lumos Pharma, Inc. 2.05 Million USD 11.409%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
Nektar Therapeutics 90.12 Million USD 97.984%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 95.538%
Arvinas, Inc. 78.5 Million USD 97.685%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD -626.8%
Nutriband Inc. 2.08 Million USD 12.867%
Tevogen Bio Holdings Inc. - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -790.686%
Tourmaline Bio, Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 95.865%
Omega Therapeutics, Inc. 3.09 Million USD 41.273%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.025%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. 7.14 Million USD 74.569%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 95.458%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD -177.829%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD -3.769%
Synlogic, Inc. 3.37 Million USD 46.099%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -393.915%
Werewolf Therapeutics, Inc. 19.94 Million USD 90.889%
Krystal Biotech, Inc. 50.69 Million USD 96.416%
Karyopharm Therapeutics Inc. 146.03 Million USD 98.756%
SpringWorks Therapeutics, Inc. 5.44 Million USD 66.642%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD -304.122%
MannKind Corporation 198.96 Million USD 99.087%
Ikena Oncology, Inc. 9.16 Million USD 80.164%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 98.398%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.363%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 96.377%
REGENXBIO Inc. 90.24 Million USD 97.987%
Ensysce Biosciences, Inc. 2.23 Million USD 18.539%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 75.376%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD -140.662%
Longeveron Inc. 709 Thousand USD -156.276%
Repare Therapeutics Inc. 51.13 Million USD 96.447%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.854%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 84.309%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -765.238%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.982%
Denali Therapeutics Inc. 330.53 Million USD 99.45%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 88.851%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 32.778%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -1092.023%
Carisma Therapeutics, Inc. 14.91 Million USD 87.821%
Unicycive Therapeutics, Inc. 675 Thousand USD -169.185%
OmniAb, Inc. 34.16 Million USD 94.682%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 91.45%
Lipocine Inc. -2.85 Million USD 163.736%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 18.847%
G1 Therapeutics, Inc. 82.51 Million USD 97.798%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 97.898%
Ocugen, Inc. 6.03 Million USD 69.897%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD -57.18%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 94.965%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 69.728%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 10.888%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.843%
Agios Pharmaceuticals, Inc. 26.82 Million USD 93.226%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.688%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 85.574%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD -280.922%
Iterum Therapeutics plc - USD -Infinity%